These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17125207)

  • 21. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel QSPR study of normalized migration time for drugs in capillary electrophoresis by new descriptors: quantum chemical investigation.
    Riahi S; Beheshti A; Ganjali MR; Norouzi P
    Electrophoresis; 2008 Oct; 29(19):4027-35. PubMed ID: 18958895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of a novel class-directed 2D fingerprint to search for structurally diverse active compounds.
    Eckert H; Bajorath J
    J Chem Inf Model; 2006; 46(6):2515-26. PubMed ID: 17125192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of descriptors based on Lipinski's rules in the QSPR study of aqueous solubilities.
    Duchowicz PR; Talevi A; Bellera C; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2007 Jun; 15(11):3711-9. PubMed ID: 17418580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method.
    Ma CY; Yang SY; Zhang H; Xiang ML; Huang Q; Wei YQ
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):677-82. PubMed ID: 18455346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model of transient drug diffusion across cornea.
    Zhang W; Prausnitz MR; Edwards A
    J Control Release; 2004 Sep; 99(2):241-58. PubMed ID: 15380634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
    Tetko IV; Poda GI
    J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative structure-property relationship study of n-octanol-water partition coefficients of some of diverse drugs using multiple linear regression.
    Ghasemi J; Saaidpour S
    Anal Chim Acta; 2007 Dec; 604(2):99-106. PubMed ID: 17996529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing drug-likeness--what are we missing?
    Vistoli G; Pedretti A; Testa B
    Drug Discov Today; 2008 Apr; 13(7-8):285-94. PubMed ID: 18405840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints.
    Tian S; Li Y; Wang J; Zhang J; Hou T
    Mol Pharm; 2011 Jun; 8(3):841-51. PubMed ID: 21548635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
    Fukunishi Y; Hojo S; Nakamura H
    J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico functional profiling of small molecules and its applications.
    Sato T; Matsuo Y; Honma T; Yokoyama S
    J Med Chem; 2008 Dec; 51(24):7705-16. PubMed ID: 19032081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of basic principles of fractals and their application to pharmacokinetics.
    Marsh RE; Riauka TA; McQuarrie SA
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):278-88. PubMed ID: 18551095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guiding molecules towards drug-likeness.
    Egan WJ; Walters WP; Murcko MA
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):540-9. PubMed ID: 12197312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Representation of chemical information in OASIS centralized 3D database for existing chemicals.
    Nikolov N; Grancharov V; Stoyanova G; Pavlov T; Mekenyan O
    J Chem Inf Model; 2006; 46(6):2537-51. PubMed ID: 17125194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic algorithm as a variable selection procedure for the simulation of 13C nuclear magnetic resonance spectra of flavonoid derivatives using multiple linear regression.
    Ghavami R; Najafi A; Sajadi M; Djannaty F
    J Mol Graph Model; 2008 Sep; 27(2):105-15. PubMed ID: 18450488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.